SP059

SP059 · Sanofi Pasteur

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SP059, covering 2013-03-29 to 2013-03-29. Get the full timeline:

Most recent: Clinical Trial Update: Study of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in Japan [Phase 3]